{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T11:39:34Z","timestamp":1792582774310,"version":"4.5.0"},"reference-count":145,"publisher":"Aging and Disease","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging and disease"],"published-print":{"date-parts":[[2023]]},"DOI":"10.14336\/ad.2023.0217","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T21:51:01Z","timestamp":1691013061000},"page":"1887","source":"Crossref","is-referenced-by-count":24,"title":["Lipidomic Alterations in the Cerebral Cortex and White Matter in Sporadic Alzheimer\u2019s Disease"],"prefix":"10.14336","volume":"14","author":[{"given":"Elia","family":"Obis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Sol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pol","family":"Andres-Benito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meritxell","family":"Mart\u00edn-Gari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e0lia","family":"Mota-Martorell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Daniel","family":"Galo-Licona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Pi\u00f1ol-Ripoll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Portero-Otin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidro","family":"Ferrer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariona","family":"Jov\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinald","family":"Pamplona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5462","reference":[{"key":"key-10.14336\/AD.2023.0217-1","doi-asserted-by":"crossref","unstructured":"Hachinski VC, Potter P, Merskey H (1987). Leuko-araiosis. Arch Neurol, 44:21-23.","DOI":"10.1001\/archneur.1987.00520130013009"},{"key":"key-10.14336\/AD.2023.0217-2","doi-asserted-by":"crossref","unstructured":"Scheltens P, Barkhof F, Leys D, Wolters EC, Ravid R, Kamphorst W (1995). Histopathologic correlates of white matter changes on MRI in Alzheimer\u2019s disease and normal aging. Neurology, 45:883-888.","DOI":"10.1212\/WNL.45.5.883"},{"key":"key-10.14336\/AD.2023.0217-3","doi-asserted-by":"crossref","unstructured":"Barber R, Scheltens P, Gholkar A, Ballard C, McKeith I, Ince P, et al. (1999). White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer\u2019s disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry, 67:66-72.","DOI":"10.1136\/jnnp.67.1.66"},{"key":"key-10.14336\/AD.2023.0217-4","doi-asserted-by":"crossref","unstructured":"Marner L, Nyengaard JR, Tang Y, Pakkenberg B (2003). Marked loss of myelinated nerve fibers in the human brain with age. J Comp Neurol, 462:144-152.","DOI":"10.1002\/cne.10714"},{"key":"key-10.14336\/AD.2023.0217-5","doi-asserted-by":"crossref","unstructured":"Holland CM, Smith EE, Csapo I, Gurol ME, Brylka DA, Killiany RJ, et al. (2008). Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke, 39:1127-1133.","DOI":"10.1161\/STROKEAHA.107.497438"},{"key":"key-10.14336\/AD.2023.0217-6","doi-asserted-by":"crossref","unstructured":"Salat DH, Greve DN, Pacheco JL, Quinn BT, Helmer KG, Buckner RL, et al. (2009). Regional white matter volume differences in nondemented aging and Alzheimer\u2019s disease. Neuroimage, 44:1247-1258.","DOI":"10.1016\/j.neuroimage.2008.10.030"},{"key":"key-10.14336\/AD.2023.0217-7","doi-asserted-by":"crossref","unstructured":"Gao J, Cheung RTF, Lee TMC, Chu LW, Chan YS, Mak HKF, et al. (2011). Possible retrogenesis observed with fiber tracking: an anteroposterior pattern of white matter disintegrity in normal aging and Alzheimer\u2019s disease. J Alzheimers Dis, 26:47-58.","DOI":"10.3233\/JAD-2011-101788"},{"key":"key-10.14336\/AD.2023.0217-8","doi-asserted-by":"crossref","unstructured":"Erten-Lyons D, Woltjer R, Kaye J, Mattek N, Dodge HH, Green S, et al. (2013). Neuropathologic basis of white matter hyperintensity accumulation with advanced age. Neurology, 81:977-983.","DOI":"10.1212\/WNL.0b013e3182a43e45"},{"key":"key-10.14336\/AD.2023.0217-9","doi-asserted-by":"crossref","unstructured":"Wharton SB, Simpson JE, Brayne C, Ince PG (2015). Age-associated white matter lesions: the MRC Cognitive Function and Ageing Study. Brain Pathol, 25:35-43.","DOI":"10.1111\/bpa.12219"},{"key":"key-10.14336\/AD.2023.0217-10","doi-asserted-by":"crossref","unstructured":"Liu H, Yang Y, Xia Y, Zhu W, Leak RK, Wei Z, et al. (2017). Aging of cerebral white matter. Ageing Res Rev, 34:64-76.","DOI":"10.1016\/j.arr.2016.11.006"},{"key":"key-10.14336\/AD.2023.0217-11","doi-asserted-by":"crossref","unstructured":"Bartzokis G, Sultzer D, Lu PH, Nuechterlein KH, Mintz J, Cummings JL (2004). Heterogeneous age-related breakdown of white matter structural integrity: Implications for cortical \u201cdisconnection\u201d in aging and Alzheimer\u2019s disease. Neurobiol Aging, 25:843-851.","DOI":"10.1016\/j.neurobiolaging.2003.09.005"},{"key":"key-10.14336\/AD.2023.0217-12","doi-asserted-by":"crossref","unstructured":"Bartzokis G, Cummings JL, Sultzer D, Henderson VW, Nuechterlein KH, Mintz J (2003). White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study. Arch Neurol, 60:393-398.","DOI":"10.1001\/archneur.60.3.393"},{"key":"key-10.14336\/AD.2023.0217-13","doi-asserted-by":"crossref","unstructured":"Bennett IJ, Madden DJ (2014). Disconnected aging: cerebral white matter integrity and age-related differences in cognition. Neuroscience, 276:187-205.","DOI":"10.1016\/j.neuroscience.2013.11.026"},{"key":"key-10.14336\/AD.2023.0217-14","doi-asserted-by":"crossref","unstructured":"Kavroulakis E, Simos PG, Kalaitzakis G, Maris TG, Karageorgou D, Zaganas I, et al. (2018). Myelin content changes in probable Alzheimer\u2019s disease and mild cognitive impairment: Associations with age and severity of neuropsychiatric impairment. J Magn Reson Imaging, 47:1359-1372.","DOI":"10.1002\/jmri.25849"},{"key":"key-10.14336\/AD.2023.0217-15","doi-asserted-by":"crossref","unstructured":"Kohama SG, Rosene DL, Sherman LS (2012). Age-related changes in human and non-human primate white matter: from myelination disturbances to cognitive decline. Age (Dordr), 34:1093-1110.","DOI":"10.1007\/s11357-011-9357-7"},{"key":"key-10.14336\/AD.2023.0217-16","doi-asserted-by":"crossref","unstructured":"Brickman AM (2013). Contemplating Alzheimer\u2019s disease and the contribution of white matter hyperintensities. Curr Neurol Neurosci Rep. 13(12):415.","DOI":"10.1007\/s11910-013-0415-7"},{"key":"key-10.14336\/AD.2023.0217-17","doi-asserted-by":"crossref","unstructured":"Molinuevo JL, Ripolles P, Sim\u00f3 M, Llad\u00f3 A, Olives J, Balasa M, et al. (2014). White matter changes in preclinical Alzheimer\u2019s disease: a magnetic resonance imaging-diffusion tensor imaging study on cognitively normal older people with positive amyloid \u03b2 protein 42 levels. Neurobiol Aging, 35:2671-2680.","DOI":"10.1016\/j.neurobiolaging.2014.05.027"},{"key":"key-10.14336\/AD.2023.0217-18","doi-asserted-by":"crossref","unstructured":"Hoy AR, Ly M, Carlsson CM, Okonkwo OC, Zetterberg H, Blennow K, et al. (2017). Microstructural white matter alterations in preclinical Alzheimer\u2019s disease detected using free water elimination diffusion tensor imaging. PLoS One. 12(3):e0173982.","DOI":"10.1371\/journal.pone.0173982"},{"key":"key-10.14336\/AD.2023.0217-19","doi-asserted-by":"crossref","unstructured":"Bouhrara M, Reiter DA, Bergeron CM, Zukley LM, Ferrucci L, Resnick SM, et al. (2018). Evidence of demyelination in mild cognitive impairment and dementia using a direct and specific magnetic resonance imaging measure of myelin content. Alzheimers Dement, 14:998-1004.","DOI":"10.1016\/j.jalz.2018.03.007"},{"key":"key-10.14336\/AD.2023.0217-20","doi-asserted-by":"crossref","unstructured":"Joki H, Higashiyama Y, Nakae Y, Kugimoto C, DoiH, KimuraK, et al. (2018). White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson\u2019s disease with dementia, and Alzheimer\u2019s disease. J Neurol Sci, 385:99-104.","DOI":"10.1016\/j.jns.2017.12.018"},{"key":"key-10.14336\/AD.2023.0217-21","doi-asserted-by":"crossref","unstructured":"Diaz JF, Hachinski VC, Boniferro M, Wong CJ, Mirsen TR, Fox H, et al. (1991). Improved recognition of leukoaraiosis and cognitive impairment in Alzheimer\u2019s disease. Arch Neurol, 48:1022-1025.","DOI":"10.1001\/archneur.1991.00530220038016"},{"key":"key-10.14336\/AD.2023.0217-22","doi-asserted-by":"crossref","unstructured":"Rose SE, Chen F, Chalk JB, Zelaya FO, Strugnell WE, Benson M, et al. (2000). Loss of connectivity in Alzheimer\u2019s disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging. J Neurol Neurosurg Psychiatry, 69:528-530.","DOI":"10.1136\/jnnp.69.4.528"},{"key":"key-10.14336\/AD.2023.0217-23","doi-asserted-by":"crossref","unstructured":"Medina D, deToledo-Morrell L, Urresta F, Gabrieli JDE, Moseley M, Fleischman D, et al. (2006). White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study. Neurobiol Aging, 27:663-672.","DOI":"10.1016\/j.neurobiolaging.2005.03.026"},{"key":"key-10.14336\/AD.2023.0217-24","doi-asserted-by":"crossref","unstructured":"Wang L, Goldstein FC, Levey AI, Lah JJ, Meltzer CC, Holder CA, et al. (2011). White matter hyperintensities and changes in white matter integrity in patients with Alzheimer\u2019s disease. Neuroradiology, 53:373-381.","DOI":"10.1007\/s00234-010-0806-2"},{"key":"key-10.14336\/AD.2023.0217-25","doi-asserted-by":"crossref","unstructured":"Selnes P, Fjell AM, Gjerstad L, Bjornerud A, Wallin A, Due-Tonnessen P, et al. (2012). White matter imaging changes in subjective and mild cognitive impairment. Alzheimers Dement. 8(5 Suppl):S112-21.","DOI":"10.1016\/j.jalz.2011.07.001"},{"key":"key-10.14336\/AD.2023.0217-26","doi-asserted-by":"crossref","unstructured":"Radanovic M, Pereira FRS, Stella F, Aprahamian I, Ferreira LK, Forlenza OV, et al. (2013). White matter abnormalities associated with Alzheimer\u2019s disease and mild cognitive impairment: a critical review of MRI studies. Expert Rev Neurother, 13:483-493.","DOI":"10.1586\/ern.13.45"},{"key":"key-10.14336\/AD.2023.0217-27","doi-asserted-by":"crossref","unstructured":"Lee S, Viqar F, Zimmerman ME, Narkhede A, Tosto G, Benzinger TLS, et al. (2016). White matter hyperintensities are a core feature of Alzheimer\u2019s disease: Evidence from the dominantly inherited Alzheimer network. Ann Neurol, 79:929-939.","DOI":"10.1002\/ana.24647"},{"key":"key-10.14336\/AD.2023.0217-28","doi-asserted-by":"crossref","unstructured":"de la Monte SM (1989). Quantitation of cerebral atrophy in preclinical and end-stage Alzheimer\u2019s disease. Ann Neurol, 25:450-459.","DOI":"10.1002\/ana.410250506"},{"key":"key-10.14336\/AD.2023.0217-29","doi-asserted-by":"crossref","unstructured":"Gouw AA, Seewann A, Vrenken H, Van Der Flier WM, Rozemuller JM, Barkhof F, et al. (2008). Heterogeneity of white matter hyperintensities in Alzheimer\u2019s disease: post-mortem quantitative MRI and neuropathology. Brain, 131:3286-3298.","DOI":"10.1093\/brain\/awn265"},{"key":"key-10.14336\/AD.2023.0217-30","doi-asserted-by":"crossref","unstructured":"Ihara M, Polvikoski TM, Hall R, Slade JY, Perry RH, Oakley AE, et al. (2010). Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer\u2019s disease, and dementia with Lewy bodies. Acta Neuropathol, 119:579-589.","DOI":"10.1007\/s00401-009-0635-8"},{"key":"key-10.14336\/AD.2023.0217-31","doi-asserted-by":"crossref","unstructured":"Ferrer I, Andr\u00e9s-Benito P (2020). White matter alterations in Alzheimer\u2019s disease without concomitant pathologies. Neuropathol Appl Neurobiol, 46:654-672.","DOI":"10.1111\/nan.12618"},{"key":"key-10.14336\/AD.2023.0217-32","doi-asserted-by":"crossref","unstructured":"Crawford MA, Bloom M, Cunnane S, Holmsen H, Ghebremeskel K, Parkington J, et al. (2001). Docosahexaenoic acid and cerebral evolution. World Rev Nutr Diet, 88:6-17.","DOI":"10.1159\/000059743"},{"key":"key-10.14336\/AD.2023.0217-33","doi-asserted-by":"crossref","unstructured":"Broadhurst CL, Wang Y, Crawford MA, Cunnane SC, Parkington JE, Schmidt WF (2002). Brain-specific lipids from marine, lacustrine, or terrestrial food resources: Potential impact on early African Homo sapiens. Comp Biochem Physiol - B Biochem Mol Biol, 131:653-673.","DOI":"10.1016\/S1096-4959(02)00002-7"},{"key":"key-10.14336\/AD.2023.0217-34","doi-asserted-by":"crossref","unstructured":"Crawford MA, Broadhurst CL, Cunnane S, Marsh DE, Agirc D, Schmidt WF, et al. (2014). Nutritional armor in evolution: docosahexaenoic acid as a determinant of neural, evolution and hominid brain development. Mil Med, 179:61-75.","DOI":"10.7205\/MILMED-D-14-00246"},{"key":"key-10.14336\/AD.2023.0217-35","doi-asserted-by":"crossref","unstructured":"Sastry PS (1985). Lipids of nervous tissue: composition and metabolism. Prog Lipid Res, 24:69-176.","DOI":"10.1016\/0163-7827(85)90011-6"},{"key":"key-10.14336\/AD.2023.0217-36","doi-asserted-by":"crossref","unstructured":"Naud\u00ed A, Cabr\u00e9 R, Jov\u00e9 M, Ayala V, Gonzalo H, Portero-Ot\u00edn M, et al.Lipidomics of Human Brain Aging and Alzheimer\u2019s Disease Pathology. Int Rev Neurobiol. 122:133-89.","DOI":"10.1016\/bs.irn.2015.05.008"},{"key":"key-10.14336\/AD.2023.0217-37","unstructured":"Horrocks LA, Van Rollings M, Yates AJ (1981). Lipid changes in the ageing brain. In The Molecular Basis of Neuropathology, DavinsonAN, ThompsonRHS, Eds. Edward Arnold: London, United Kingdom"},{"key":"key-10.14336\/AD.2023.0217-38","doi-asserted-by":"crossref","unstructured":"S\u00f6derberg M, Edlund C, Kristensson K, Dallner G (1990). Lipid compositions of different regions of the human brain during aging. J Neurochem, 54:415-23.","DOI":"10.1111\/j.1471-4159.1990.tb01889.x"},{"key":"key-10.14336\/AD.2023.0217-39","doi-asserted-by":"crossref","unstructured":"Hancock SE, Friedrich MG, Mitchell TW, Truscott RJW, Else PL (2017). The phospholipid composition of the human entorhinal cortex remains relatively stable over 80 years of adult aging. GeroScience, 39:73-82.","DOI":"10.1007\/s11357-017-9961-2"},{"key":"key-10.14336\/AD.2023.0217-40","doi-asserted-by":"crossref","unstructured":"Cabr\u00e9 R, Naud\u00ed A, Dominguez-Gonzalez M, Jov\u00e9 M, Ayala V, Mota-Martorell N, et al. (2018). Lipid Profile in Human Frontal Cortex Is Sustained Throughout Healthy Adult Life Span to Decay at Advanced Ages. J Gerontol A Biol Sci Med Sci. 9;73(6):703-710.","DOI":"10.1093\/gerona\/glx164"},{"key":"key-10.14336\/AD.2023.0217-41","doi-asserted-by":"crossref","unstructured":"D\u00edaz M, Fabelo N, Ferrer I, Mar\u00edn R (2018). \u201cLipid raft aging\u201d in the human frontal cortex during nonpathological aging: gender influences and potential implications in Alzheimer\u2019s disease. Neurobiol Aging, 67:42-52.","DOI":"10.1016\/j.neurobiolaging.2018.02.022"},{"key":"key-10.14336\/AD.2023.0217-42","doi-asserted-by":"crossref","unstructured":"Dom\u00ednguez-Gonz\u00e1lez M, Puigpin\u00f3s M, Jov\u00e9 M, Naudi A, Portero-Ot\u00edn M, Pamplona R, et al. (2018). Regional vulnerability to lipoxidative damage and inflammation in normal human brain aging. Exp Gerontol, 111:218-228.","DOI":"10.1016\/j.exger.2018.07.023"},{"key":"key-10.14336\/AD.2023.0217-43","doi-asserted-by":"crossref","unstructured":"Jov\u00e9 M, Pradas I, Dominguez-Gonzalez M, Ferrer I, Pamplona R (2019). Lipids and lipoxidation in human brain aging. Mitochondrial ATP-synthase as a key lipoxidation target. Redox Biol. 23:101082.","DOI":"10.1016\/j.redox.2018.101082"},{"key":"key-10.14336\/AD.2023.0217-44","doi-asserted-by":"crossref","unstructured":"Pamplona R, Borras C, Jov\u00e9 M, Pradas I, Ferrer I, Vi\u00f1a J (2019). Redox lipidomics to better understand brain aging and function. Free Radic Biol Med. 144:310-321.","DOI":"10.1016\/j.freeradbiomed.2019.03.016"},{"key":"key-10.14336\/AD.2023.0217-45","doi-asserted-by":"crossref","unstructured":"Jov\u00e9 M, Mota-Martorell N, Torres P, Portero-Otin M, Ferrer I, Pamplona R (2021). New insights into human prefrontal cortex aging with a lipidomics approach. Expert Rev Proteomics, 18:333-344.","DOI":"10.1080\/14789450.2021.1940142"},{"key":"key-10.14336\/AD.2023.0217-46","doi-asserted-by":"crossref","unstructured":"Mota-Martorell N, Andr\u00e9s-Benito P, Mart\u00edn-Gari M, Galo-Licona JD, Sol J, Fern\u00e1ndez-Bernal A, et al. (2022). Selective brain regional changes in lipid profile with human aging. GeroScience, 44:763-783.","DOI":"10.1007\/s11357-022-00527-1"},{"key":"key-10.14336\/AD.2023.0217-47","doi-asserted-by":"crossref","unstructured":"Svennerholm L, Bostr\u00f6m K, Helander CG, Jungbjer B (1991). Membrane lipids in the aging human brain. J Neurochem, 56:2051-2059.","DOI":"10.1111\/j.1471-4159.1991.tb03466.x"},{"key":"key-10.14336\/AD.2023.0217-48","doi-asserted-by":"crossref","unstructured":"Svennerholm L, Bostr\u00f6m K, Jungbjer B, Olsson L (1994). Membrane lipids of adult human brain: lipid composition of frontal and temporal lobe in subjects of age 20 to 100 years. J Neurochem, 63:1802-1811.","DOI":"10.1046\/j.1471-4159.1994.63051802.x"},{"key":"key-10.14336\/AD.2023.0217-49","doi-asserted-by":"crossref","unstructured":"McNamara RK, Liu Y, Jandacek R, Rider T, Tso P (2008). The aging human orbitofrontal cortex: decreasing polyunsaturated fatty acid composition and associated increases in lipogenic gene expression and stearoyl-CoA desaturase activity. Prostaglandins Leukot Essent Fatty Acids, 78:293-304.","DOI":"10.1016\/j.plefa.2008.04.001"},{"key":"key-10.14336\/AD.2023.0217-50","doi-asserted-by":"crossref","unstructured":"Ledesma MD, Martin MG, Dotti CG (2012). Lipid changes in the aged brain: effect on synaptic function and neuronal survival. Prog Lipid Res, 51:23-35.","DOI":"10.1016\/j.plipres.2011.11.004"},{"key":"key-10.14336\/AD.2023.0217-51","doi-asserted-by":"crossref","unstructured":"Hancock SE, Friedrich MG, Mitchell TW, Truscott RJW, Else PL (2015). Decreases in Phospholipids Containing Adrenic and Arachidonic Acids Occur in the Human Hippocampus over the Adult Lifespan. Lipids, 50:861-872.","DOI":"10.1007\/s11745-015-4030-z"},{"key":"key-10.14336\/AD.2023.0217-52","doi-asserted-by":"crossref","unstructured":"Norris SE, Friedrich MG, Mitchell TW, Truscott RJW, Else PL (2015). Human prefrontal cortex phospholipids containing docosahexaenoic acid increase during normal adult aging, whereas those containing arachidonic acid decrease. Neurobiol Aging, 36:1659-1669.","DOI":"10.1016\/j.neurobiolaging.2015.01.002"},{"key":"key-10.14336\/AD.2023.0217-53","doi-asserted-by":"crossref","unstructured":"Dom\u00ednguez M, De Oliveira E, Odena MA, Portero M, Pamplona R, Ferrer I (2016). Redox proteomic profiling of neuroketal-adducted proteins in human brain: Regional vulnerability at middle age increases in the elderly. Free Radic Biol Med, 95:1-15.","DOI":"10.1016\/j.freeradbiomed.2016.02.034"},{"key":"key-10.14336\/AD.2023.0217-54","doi-asserted-by":"crossref","unstructured":"Cabr\u00e9 R, Naud\u00ed A, Dominguez-Gonzalez M, Ayala V, Jov\u00e9 M, Mota-Martorell N, et al. (2017). Sixty years old is the breakpoint of human frontal cortex aging. Free Radic Biol Med. 103:14-22.","DOI":"10.1016\/j.freeradbiomed.2016.12.010"},{"key":"key-10.14336\/AD.2023.0217-55","doi-asserted-by":"crossref","unstructured":"Farooqui AA, Liss L, Horrocks LA (1988). Neurochemical aspects of Alzheimer\u2019s disease: involvement of membrane phospholipids. Metab Brain Dis, 3:19-35.","DOI":"10.1007\/BF01001351"},{"key":"key-10.14336\/AD.2023.0217-56","doi-asserted-by":"crossref","unstructured":"Kosicek M, Hecimovic S (2013). Phospholipids and Alzheimer\u2019s Disease: Alterations, Mechanisms and Potential Biomarkers. Int J Mol Sci, 14(1):1310-22.","DOI":"10.3390\/ijms14011310"},{"key":"key-10.14336\/AD.2023.0217-57","doi-asserted-by":"crossref","unstructured":"Sultana R, Perluigi M, Butterfield DA (2013). Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain. Free Radic Biol Med, 62:157-169.","DOI":"10.1016\/j.freeradbiomed.2012.09.027"},{"key":"key-10.14336\/AD.2023.0217-58","doi-asserted-by":"crossref","unstructured":"Touboul D, Gaudin M (2014). Lipidomics of Alzheimer\u2019s disease. Bioanalysis, 6:541-561.","DOI":"10.4155\/bio.13.346"},{"key":"key-10.14336\/AD.2023.0217-59","doi-asserted-by":"crossref","unstructured":"Zabel M, Nackenoff A, Kirsch WM, Harrison FE, Perry G, Schrag M (2018). Markers of oxidative damage to lipids, nucleic acids and proteins and antioxidant enzymes activities in Alzheimer\u2019s disease brain: A meta-analysis in human pathological specimens. Free Radic Biol Med, 115:351-360.","DOI":"10.1016\/j.freeradbiomed.2017.12.016"},{"key":"key-10.14336\/AD.2023.0217-60","doi-asserted-by":"crossref","unstructured":"Jov\u00e9 M, Mota-Martorell N, Torres P, Ayala V, Portero-Otin M, Ferrer I, et al. (2021). The Causal Role of Lipoxidative Damage in Mitochondrial Bioenergetic Dysfunction Linked to Alzheimer\u2019s Disease Pathology. Life (Basel, Switzerland). 11(5):388.","DOI":"10.3390\/life11050388"},{"key":"key-10.14336\/AD.2023.0217-61","doi-asserted-by":"crossref","unstructured":"Pamplona R, Dalf\u00f3 E, Ayala V, Bellmunt MJ, Prat J, Ferrer I, et al. (2005). Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation. Effects of Alzheimer disease and identification of lipoxidation targets. J Biol Chem, 280:21522-30.","DOI":"10.1074\/jbc.M502255200"},{"key":"key-10.14336\/AD.2023.0217-62","doi-asserted-by":"crossref","unstructured":"Han X (2010). Multi-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer\u2019s disease. Biochim Biophys Acta, 1801:774-783.","DOI":"10.1016\/j.bbalip.2010.01.010"},{"key":"key-10.14336\/AD.2023.0217-63","doi-asserted-by":"crossref","unstructured":"Haughey NJ, Bandaru VVR, Bae M, Mattson MP (2010). Roles for dysfunctional sphingolipid metabolism in Alzheimer\u2019s disease neuropathogenesis. Biochim Biophys Acta, 1801:878-886.","DOI":"10.1016\/j.bbalip.2010.05.003"},{"key":"key-10.14336\/AD.2023.0217-64","doi-asserted-by":"crossref","unstructured":"Mart\u00edn V, Fabelo N, Santpere G, Puig B, Mar\u00edn R, Ferrer I, et al. (2010). Lipid alterations in lipid rafts from Alzheimer\u2019s disease human brain cortex. J Alzheimers Dis, 19:489-502.","DOI":"10.3233\/JAD-2010-1242"},{"key":"key-10.14336\/AD.2023.0217-65","doi-asserted-by":"crossref","unstructured":"Terni B, Boada J, Portero-Otin M, Pamplona R, Ferrer I (2010). Mitochondrial ATP-synthase in the entorhinal cortex is a target of oxidative stress at stages I\/II of Alzheimer\u2019s disease pathology. Brain Pathol, 20:222-33.","DOI":"10.1111\/j.1750-3639.2009.00266.x"},{"key":"key-10.14336\/AD.2023.0217-66","doi-asserted-by":"crossref","unstructured":"Frisardi V, Panza F, Seripa D, Farooqui T, Farooqui AA (2011). Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer\u2019s disease pathology. Prog Lipid Res, 50:313-330.","DOI":"10.1016\/j.plipres.2011.06.001"},{"key":"key-10.14336\/AD.2023.0217-67","doi-asserted-by":"crossref","unstructured":"Wood PL (2012). Lipidomics of Alzheimer\u2019s disease: Current status. Alzheimer\u2019s Res Ther, 4:1-10.","DOI":"10.1186\/alzrt103"},{"key":"key-10.14336\/AD.2023.0217-68","doi-asserted-by":"crossref","unstructured":"Zhu X, Castellani RJ, Moreira PI, Aliev G, Shenk JC, Siedlak SL, et al. (2012). Hydroxynonenal-generated crosslinking fluorophore accumulation in Alzheimer disease reveals a dichotomy of protein turnover. Free Radic Biol Med, 52:699-704.","DOI":"10.1016\/j.freeradbiomed.2011.11.004"},{"key":"key-10.14336\/AD.2023.0217-69","doi-asserted-by":"crossref","unstructured":"Wood PL, Barnette BL, Kaye JA, Quinn JF, Woltjer RL (2015). Non-targeted lipidomics of CSF and frontal cortex grey and white matter in control, mild cognitive impairment, and Alzheimer\u2019s disease subjects. Acta Neuropsychiatr, 27:270-278.","DOI":"10.1017\/neu.2015.18"},{"key":"key-10.14336\/AD.2023.0217-70","doi-asserted-by":"crossref","unstructured":"O'Brien JS, Sampson EL (1965). Lipid composition of the normal human brain: gray matter, white matter, and myelin. [J] Lipid Res. 6(4):537-44.","DOI":"10.1016\/S0022-2275(20)39619-X"},{"key":"key-10.14336\/AD.2023.0217-71","doi-asserted-by":"crossref","unstructured":"Ferrer I (2015). Selection of controls in the study of human neurodegenerative diseases in old age. J Neural Transm, 122:941-7.","DOI":"10.1007\/s00702-014-1287-y"},{"key":"key-10.14336\/AD.2023.0217-72","doi-asserted-by":"crossref","unstructured":"Ferrer I, Santpere G, Arzberger T, Bell J, Blanco R, Boluda S, et al. (2007). Brain protein preservation largely depends on the postmortem storage temperature: implications for study of proteins in human neurologic diseases and management of brain banks: a BrainNet Europe Study. J Neuropathol Exp Neurol, 66:35-46.","DOI":"10.1097\/nen.0b013e31802c3e7d"},{"key":"key-10.14336\/AD.2023.0217-73","doi-asserted-by":"crossref","unstructured":"Ferrer I, Martinez A, Boluda S, Parchi P, Barrachina M (2008). Brain banks: benefits, limitations and cautions concerning the use of post-mortem brain tissue for molecular studies. Cell Tissue Bank, 9:181-94.","DOI":"10.1007\/s10561-008-9077-0"},{"key":"key-10.14336\/AD.2023.0217-74","doi-asserted-by":"crossref","unstructured":"Braak H, Braak E (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol, 82:239-259.","DOI":"10.1007\/BF00308809"},{"key":"key-10.14336\/AD.2023.0217-75","doi-asserted-by":"crossref","unstructured":"Holman RT (1954). Autoxidation of fats and related substances. Prog Chem Fats Other Lipids, 2:51-98.","DOI":"10.1016\/0079-6832(54)90004-X"},{"key":"key-10.14336\/AD.2023.0217-76","doi-asserted-by":"crossref","unstructured":"Yin H, Xu L, Porter NA (2011). Free radical lipid peroxidation: mechanisms and analysis. Chem Rev, 111:5944-5972.","DOI":"10.1021\/cr200084z"},{"key":"key-10.14336\/AD.2023.0217-77","doi-asserted-by":"crossref","unstructured":"Cosgrove JP, Church DF, Pryor WA (1987). The kinetics of the autoxidation of polyunsaturated fatty acids. Lipids, 22:299-304.","DOI":"10.1007\/BF02533996"},{"key":"key-10.14336\/AD.2023.0217-78","doi-asserted-by":"crossref","unstructured":"Guillou H, Zadravec D, Martin PGP, Jacobsson A (2010). The key roles of elongases and desaturases in mammalian fatty acid metabolism: Insights from transgenic mice. Prog Lipid Res, 49:186-99.","DOI":"10.1016\/j.plipres.2009.12.002"},{"key":"key-10.14336\/AD.2023.0217-79","doi-asserted-by":"crossref","unstructured":"Pizarro C, Arezana-R\u00e1mila I, P\u00e9rez-del-Notario N, P\u00e9rez-Matute P, Gonz\u00e1lez-S\u00e1iz JM (2013). Plasma Lipidomic Pro fi ling Method Based on Ultrasound Extraction and Liquid Chromatography Mass Spectrometry. Anal Chem, 85:12085-12092.","DOI":"10.1021\/ac403181c"},{"key":"key-10.14336\/AD.2023.0217-80","doi-asserted-by":"crossref","unstructured":"Pradas I, Huynh K, Cabr\u00e9 R, Ayala V, Meikle PJ, Jov\u00e9 M, et al. (2018). Lipidomics Reveals a Tissue-Specific Fingerprint. Front Physiol. 9:1165.","DOI":"10.3389\/fphys.2018.01165"},{"key":"key-10.14336\/AD.2023.0217-81","doi-asserted-by":"crossref","unstructured":"Castro-Perez JM, Kamphorst J, DeGroot J, Lafeber F, Goshawk J, Yu K, et al. (2010). Comprehensive LC-MS E lipidomic analysis using a shotgun approach and its application to biomarker detection and identification in osteoarthritis patients. J Proteome Res, 9:2377-89.","DOI":"10.1021\/pr901094j"},{"key":"key-10.14336\/AD.2023.0217-82","doi-asserted-by":"crossref","unstructured":"Pradas I, Rovira-Llopis S, Naud\u00ed A, Ba\u00f1uls C, Rocha M, Hernandez-Mijares A, et al. (2019). Metformin induces lipid changes on sphingolipid species and oxidized lipids in polycystic ovary syndrome women. Sci Rep, 9(1):16033.","DOI":"10.1038\/s41598-019-52263-w"},{"key":"key-10.14336\/AD.2023.0217-83","doi-asserted-by":"crossref","unstructured":"Dunn WB, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S, Anderson N, et al. (2011). Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc, 6:1060-1083.","DOI":"10.1038\/nprot.2011.335"},{"key":"key-10.14336\/AD.2023.0217-84","doi-asserted-by":"crossref","unstructured":"Broadhurst D, Goodacre R, Reinke SN, Kuligowski J, Wilson ID, Lewis MR, et al. (2018). Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies. Metabolomics, 14(6):72.","DOI":"10.1007\/s11306-018-1367-3"},{"key":"key-10.14336\/AD.2023.0217-85","doi-asserted-by":"crossref","unstructured":"Wishart DS, Feunang YD, Marcu A, Guo AC, Liang K, V\u00e1zquez-Fresno R, et al. (2018). HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res, 46(D1):D608-D617.","DOI":"10.1093\/nar\/gkx1089"},{"key":"key-10.14336\/AD.2023.0217-86","doi-asserted-by":"crossref","unstructured":"Fahy E, Sud M, Cotter D, Subramaniam S (2007). LIPID MAPS online tools for lipid research. Nucleic Acids Res, 35:W606-12.","DOI":"10.1093\/nar\/gkm324"},{"key":"key-10.14336\/AD.2023.0217-87","doi-asserted-by":"crossref","unstructured":"Koelmel JP, Kroeger NM, Ulmer CZ, Bowden JA, Patterson RE, Cochran JA, et al. (2017). LipidMatch: an automated workflow for rule-based lipid identification using untargeted high-resolution tandem mass spectrometry data. BMC Bioinformatics, 18(1):331.","DOI":"10.1186\/s12859-017-1744-3"},{"key":"key-10.14336\/AD.2023.0217-88","doi-asserted-by":"crossref","unstructured":"Pang Z, Chong J, Li S, Xia J (2020). MetaboAnalystR 3.0: Toward an Optimized Workflow for Global Metabolomics. Metabolites. 10(5):186.","DOI":"10.3390\/metabo10050186"},{"key":"key-10.14336\/AD.2023.0217-89","unstructured":"R Core Team R Foundation for Statistical Computing, Vienna A (2020). R: A language and environment for statistical computing. https:\/\/www.r-project.org\/. Accessed 6 Nov 2020."},{"key":"key-10.14336\/AD.2023.0217-90","doi-asserted-by":"crossref","unstructured":"S\u00f6derberg M, Edlund C, Kristensson K, Dallner G (1991). Fatty acid composition of brain phospholipids in aging and in Alzheimer\u2019s disease. Lipids, 26:421-5.","DOI":"10.1007\/BF02536067"},{"key":"key-10.14336\/AD.2023.0217-91","doi-asserted-by":"crossref","unstructured":"Skinner ER, Watt C, Besson JAO, Best P V. (1993). Differences in the fatty acid composition of the grey and white matter of different regions of the brains of patients with Alzheimer\u2019s disease and control subjects. Brain, 116(Pt 3):717-725.","DOI":"10.1093\/brain\/116.3.717"},{"key":"key-10.14336\/AD.2023.0217-92","doi-asserted-by":"crossref","unstructured":"Veloso A, Astigarraga E, Barreda-G\u00f3mez G, Manuel I, Ferrer I, Giralt MT, et al. (2011). Anatomical distribution of lipids in human brain cortex by imaging mass spectrometry. J Am Soc Mass Spectrom, 22:329-338.","DOI":"10.1007\/s13361-010-0024-5"},{"key":"key-10.14336\/AD.2023.0217-93","doi-asserted-by":"crossref","unstructured":"Wood PL, Hauther KA, Scarborough JH, Craney DJ, Dudzik B, Cebak JE, et al. (2021). Human brain lipidomics: Utilities of chloride adducts in flow injection analysis. Life (Basel). 11(5): 403.","DOI":"10.3390\/life11050403"},{"key":"key-10.14336\/AD.2023.0217-94","doi-asserted-by":"crossref","unstructured":"Lam SM, Wang Y, Duan X, Wenk MR, Kalaria RN, Chen CP, et al. (2014). The brain lipidomes of subcortical ischemic vascular dementia and mixed dementia. Neurobiol Aging, 35(10):2369-81.","DOI":"10.1016\/j.neurobiolaging.2014.02.025"},{"key":"key-10.14336\/AD.2023.0217-95","doi-asserted-by":"crossref","unstructured":"Hunter M, Demarais NJ, Faull RLM, Grey AC, Curtis MA (2021). An imaging mass spectrometry atlas of lipids in the human neurologically normal and Huntington\u2019s disease caudate nucleus. J Neurochem, 157:2158-2172.","DOI":"10.1111\/jnc.15325"},{"key":"key-10.14336\/AD.2023.0217-96","doi-asserted-by":"crossref","unstructured":"SoOderberg M, Edlund C, Alafuzoff I, Kristensson K, Dallner G (1992). Lipid composition in different regions of the brain in Alzheimer\u2019s disease\/senile dementia of Alzheimer\u2019s type. J Neurochem, 59:1646-1653.","DOI":"10.1111\/j.1471-4159.1992.tb10994.x"},{"key":"key-10.14336\/AD.2023.0217-97","doi-asserted-by":"crossref","unstructured":"Svennerholm L, Gottfries C -G (1994). Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II). J Neurochem, 62:1039-1047.","DOI":"10.1046\/j.1471-4159.1994.62031039.x"},{"key":"key-10.14336\/AD.2023.0217-98","doi-asserted-by":"crossref","unstructured":"Roher AE, Weiss N, Kokjohn TA, Kuo YM, Kalback W, Anthony J, et al. (2002). Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer\u2019s disease. Biochemistry, 41:11080-11090.","DOI":"10.1021\/bi026173d"},{"key":"key-10.14336\/AD.2023.0217-99","doi-asserted-by":"crossref","unstructured":"Han X, M Holtzman D, McKeel DW, Kelley J, Morris JC (2002). Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer\u2019s disease: potential role in disease pathogenesis. J Neurochem, 82:809-18.","DOI":"10.1046\/j.1471-4159.2002.00997.x"},{"key":"key-10.14336\/AD.2023.0217-100","doi-asserted-by":"crossref","unstructured":"Hejazi L, Wong JWH, Cheng D, Proschogo N, Ebrahimi D, Garner B, et al. (2011). Mass and relative elution time profiling: two-dimensional analysis of sphingolipids in Alzheimer\u2019s disease brains. Biochem J, 438:165-175.","DOI":"10.1042\/BJ20110566"},{"key":"key-10.14336\/AD.2023.0217-101","doi-asserted-by":"crossref","unstructured":"Couttas TA, Kain N, Suchowerska AK, Quek LE, Turner N, Fath T, et al. (2016). Loss of ceramide synthase 2 activity, necessary for myelin biosynthesis, precedes tau pathology in the cortical pathogenesis of Alzheimer\u2019s disease. Neurobiol Aging, 43:89-100.","DOI":"10.1016\/j.neurobiolaging.2016.03.027"},{"key":"key-10.14336\/AD.2023.0217-102","doi-asserted-by":"crossref","unstructured":"Piomelli D, Astarita G, Rapaka R (2007). A neuroscientist\u2019s guide to lipidomics. Nat Rev Neurosci, 8:743-754.","DOI":"10.1038\/nrn2233"},{"key":"key-10.14336\/AD.2023.0217-103","doi-asserted-by":"crossref","unstructured":"Farooqui AA (2009). Lipid mediators in the neural cell nucleus: their metabolism, signaling, and association with neurological disorders. Neuroscientist, 15:392-407.","DOI":"10.1177\/1073858409337035"},{"key":"key-10.14336\/AD.2023.0217-104","doi-asserted-by":"crossref","unstructured":"Naud\u00ed A, Cabr\u00e9 R, Ayala V, Jov\u00e9 M, Mota-Martorell N, Portero-Ot\u00edn M, et al. (2017). Region-specific vulnerability to lipid peroxidation and evidence of neuronal mechanisms for polyunsaturated fatty acid biosynthesis in the healthy adult human central nervous system. Biochim Biophys Acta - Mol Cell Biol Lipids. 1862(5):485-495.","DOI":"10.1016\/j.bbalip.2017.02.001"},{"key":"key-10.14336\/AD.2023.0217-105","doi-asserted-by":"crossref","unstructured":"Patel R, Santoro A, Hofer P, Tan D, Oberer M, Nelson AT, et al. (2022). ATGL is a biosynthetic enzyme for fatty acid esters of hydroxy fatty acids. Nature, 606(7916):968-975.","DOI":"10.1038\/s41586-022-04787-x"},{"key":"key-10.14336\/AD.2023.0217-106","doi-asserted-by":"crossref","unstructured":"Kuda O, Brezinova M, Silhavy J, Landa V, Zidek V, Dodia C, et al. (2018). Nrf2-Mediated antioxidant defense and peroxiredoxin 6 are linked to biosynthesis of palmitic acid ester of 9-Hydroxystearic acid. Diabetes, 67:1190-1199.","DOI":"10.2337\/db17-1087"},{"key":"key-10.14336\/AD.2023.0217-107","doi-asserted-by":"crossref","unstructured":"Wood PL (2020). Fatty Acyl Esters of Hydroxy Fatty Acid (FAHFA) Lipid Families. Metabolites, 10:1-8.","DOI":"10.3390\/metabo10120512"},{"key":"key-10.14336\/AD.2023.0217-108","doi-asserted-by":"crossref","unstructured":"Kellar D, Craft S (2020). Brain insulin resistance in Alzheimer\u2019s disease and related disorders: mechanisms and therapeutic approaches. Lancet Neurol, 19:758-766.","DOI":"10.1016\/S1474-4422(20)30231-3"},{"key":"key-10.14336\/AD.2023.0217-109","doi-asserted-by":"crossref","unstructured":"Carrasco S, M\u00e9rida I (2007). Diacylglycerol, when simplicity becomes complex. Trends Biochem Sci, 32:27-36.","DOI":"10.1016\/j.tibs.2006.11.004"},{"key":"key-10.14336\/AD.2023.0217-110","doi-asserted-by":"crossref","unstructured":"Almena M, M\u00e9rida I (2011). Shaping up the membrane: diacylglycerol coordinates spatial orientation of signaling. Trends Biochem Sci, 36:593-603.","DOI":"10.1016\/j.tibs.2011.06.005"},{"key":"key-10.14336\/AD.2023.0217-111","doi-asserted-by":"crossref","unstructured":"Sakane F, Hoshino F, Murakami C (2020). New Era of Diacylglycerol Kinase, Phosphatidic Acid and Phosphatidic Acid-Binding Protein. Int J Mol Sci, 21(18):6794.","DOI":"10.3390\/ijms21186794"},{"key":"key-10.14336\/AD.2023.0217-112","doi-asserted-by":"crossref","unstructured":"Chan RB, Oliveira TG, Cortes EP, Honig LS, Duff KE, Small SA, et al. (2012). Comparative lipidomic analysis of mouse and human brain with Alzheimer disease. J Biol Chem, 287:2678-2688.","DOI":"10.1074\/jbc.M111.274142"},{"key":"key-10.14336\/AD.2023.0217-113","doi-asserted-by":"crossref","unstructured":"Wood PL, Medicherla S, Sheikh N, Terry B, Phillipps A, Kaye JA, et al. (2015). Targeted Lipidomics of Fontal Cortex and Plasma Diacylglycerols (DAG) in Mild Cognitive Impairment and Alzheimer\u2019s Disease: Validation of DAG Accumulation Early in the Pathophysiology of Alzheimer\u2019s Disease. J Alzheimers Dis, 48:537-46.","DOI":"10.3233\/JAD-150336"},{"key":"key-10.14336\/AD.2023.0217-114","doi-asserted-by":"crossref","unstructured":"Ferrer I, Andr\u00e9s-Benito P, Aus\u00edn K, Pamplona R, del Rio JA, Fern\u00e1ndez-Irigoyen J, et al. (2021). Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer\u2019s disease. 31(6):e12996.","DOI":"10.1111\/bpa.12996"},{"key":"key-10.14336\/AD.2023.0217-115","doi-asserted-by":"crossref","unstructured":"Teixeira V, Maciel P, Costa V (2021). Leading the way in the nervous system: Lipid Droplets as new players in health and disease. Biochim Biophys acta Mol cell Biol lipids. 1866(1):158820.","DOI":"10.1016\/j.bbalip.2020.158820"},{"key":"key-10.14336\/AD.2023.0217-116","doi-asserted-by":"crossref","unstructured":"Ferrer I (2009). Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer\u2019s disease. J Bioenerg Biomembr, 41:425-31.","DOI":"10.1007\/s10863-009-9243-5"},{"key":"key-10.14336\/AD.2023.0217-117","doi-asserted-by":"crossref","unstructured":"Vance JE, Vance DE (2004). Phospholipid biosynthesis in mammalian cells. Biochem Cell Biol, 82:113-128.","DOI":"10.1139\/o03-073"},{"key":"key-10.14336\/AD.2023.0217-118","doi-asserted-by":"crossref","unstructured":"Wallner S, Schmitz G (2011). Plasmalogens the neglected regulatory and scavenging lipid species. Chem Phys Lipids, 164:573-589.","DOI":"10.1016\/j.chemphyslip.2011.06.008"},{"key":"key-10.14336\/AD.2023.0217-119","doi-asserted-by":"crossref","unstructured":"Dean JM, Lodhi IJ (2018). Structural and functional roles of ether lipids. Protein Cell, 9:196-206.","DOI":"10.1007\/s13238-017-0423-5"},{"key":"key-10.14336\/AD.2023.0217-120","doi-asserted-by":"crossref","unstructured":"Braverman NE, Moser AB (2012). Functions of plasmalogen lipids in health and disease. Biochim Biophys Acta, 1822:1442-1452.","DOI":"10.1016\/j.bbadis.2012.05.008"},{"key":"key-10.14336\/AD.2023.0217-121","doi-asserted-by":"crossref","unstructured":"Goldfine H (2010). The appearance, disappearance and reappearance of plasmalogens in evolution. Prog Lipid Res, 49:493-498.","DOI":"10.1016\/j.plipres.2010.07.003"},{"key":"key-10.14336\/AD.2023.0217-122","doi-asserted-by":"crossref","unstructured":"Huynh K, Martins RN, Meikle PJ (2017). Lipidomic Profiles in Diabetes and Dementia. J Alzheimers Dis, 59:433-444.","DOI":"10.3233\/JAD-161215"},{"key":"key-10.14336\/AD.2023.0217-123","doi-asserted-by":"crossref","unstructured":"Jov\u00e9 M, Mota-Martorell N, Obis \u00c8, Sol J, Mart\u00edn-Gar\u00ed M, Ferrer I, et al. (2023). Ether Lipid-Mediated Antioxidant Defense in Alzheimer's Disease. Antioxidants 12(2), 293","DOI":"10.3390\/antiox12020293"},{"key":"key-10.14336\/AD.2023.0217-124","doi-asserted-by":"crossref","unstructured":"Puigserver P, Spiegelman BM (2003). Peroxisome Proliferator-Activated Receptor-\u03b3 Coactivator 1\u03b1 (PGC-1\u03b1): Transcriptional Coactivator and Metabolic Regulator. Endocr Rev, 24:78-90.","DOI":"10.1210\/er.2002-0012"},{"key":"key-10.14336\/AD.2023.0217-125","doi-asserted-by":"crossref","unstructured":"Zhang Y, Chen C, Jiang Y, Wang S, Wu X, Wang K (2017). PPAR\u03b3 coactivator-1\u03b1 (PGC-1\u03b1) protects neuroblastoma cells against amyloid-beta (A\u03b2) induced cell death and neuroinflammation via NF-\u039aB pathway. BMC Neurosci, 18:1-8.","DOI":"10.1186\/s12868-017-0387-7"},{"key":"key-10.14336\/AD.2023.0217-126","doi-asserted-by":"crossref","unstructured":"Katsouri L, Parr C, Bogdanovic N, Willem M, Sastre M (2011). PPAR\u03b3 Co-Activator-1\u03b1 (PGC-1\u03b1) Reduces Amyloid-\u03b2 Generation Through a PPAR\u03b3-Dependent Mechanism. J Alzheimer\u2019s Dis, 25:151-162.","DOI":"10.3233\/JAD-2011-101356"},{"key":"key-10.14336\/AD.2023.0217-127","doi-asserted-by":"crossref","unstructured":"Katsouri L, Lim YM, Blondrath K, Eleftheriadou I, Lombardero L, Birch AM, et al. (2016). PPAR\u03b3-coactivator-1\u03b1 gene transfer reduces neuronal loss and amyloid-\u03b2 generation by reducing \u03b2-secretase in an Alzheimer\u2019s disease model. Proc Natl Acad Sci U S A, 113:12292-12297.","DOI":"10.1073\/pnas.1606171113"},{"key":"key-10.14336\/AD.2023.0217-128","doi-asserted-by":"crossref","unstructured":"Heneka MT, Landreth GE (2007). PPARs in the brain. Biochim Biophys Acta - Mol Cell Biol Lipids, 1771:1031-1045.","DOI":"10.1016\/j.bbalip.2007.04.016"},{"key":"key-10.14336\/AD.2023.0217-129","doi-asserted-by":"crossref","unstructured":"Zeng Y, Xie K, Dong H, Zhang H, Wang F, Li Y, et al. (2012). Hyperbaric oxygen preconditioning protects cortical neurons against oxygen-glucose deprivation injury: Role of peroxisome proliferator-activated receptor-gamma. Brain Res, 1452:140-150.","DOI":"10.1016\/j.brainres.2012.02.063"},{"key":"key-10.14336\/AD.2023.0217-130","doi-asserted-by":"crossref","unstructured":"W\u00f3jtowicz S, Strosznajder AK, Je\u017cyna M, Strosznajder JB (2020). The Novel Role of PPAR Alpha in the Brain: Promising Target in Therapy of Alzheimer\u2019s Disease and Other Neurodegenerative Disorders. Neurochem Res, 45:972-988.","DOI":"10.1007\/s11064-020-02993-5"},{"key":"key-10.14336\/AD.2023.0217-131","doi-asserted-by":"crossref","unstructured":"Posse de Chaves E, Sipione S (2010). Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction. FEBS Lett, 584:1748-1759.","DOI":"10.1016\/j.febslet.2009.12.010"},{"key":"key-10.14336\/AD.2023.0217-132","doi-asserted-by":"crossref","unstructured":"Hannun YA, Obeid LM (2018). Sphingolipids and their metabolism in physiology and disease. Nat Rev Mol Cell Biol, 19:175-191.","DOI":"10.1038\/nrm.2017.107"},{"key":"key-10.14336\/AD.2023.0217-133","doi-asserted-by":"crossref","unstructured":"Trayssac M, Hannun YA, Obeid LM (2018). Role of sphingolipids in senescence: implication in aging and age-related diseases. J Clin Invest, 128(7):2702-2712.","DOI":"10.1172\/JCI97949"},{"key":"key-10.14336\/AD.2023.0217-134","doi-asserted-by":"crossref","unstructured":"Meikle PJ, Summers SA (2017). Sphingolipids and phospholipids in insulin resistance and related metabolic disorders. Nat Rev Endocrinol, 13:79-91.","DOI":"10.1038\/nrendo.2016.169"},{"key":"key-10.14336\/AD.2023.0217-135","doi-asserted-by":"crossref","unstructured":"Fabelo N, Mart\u00edn V, Santpere G, Mar\u00edn R, Torrent L, Ferrer I, et al. (2011). Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson\u2019s disease and incidental Parkinson\u2019s disease. Mol Med, 17:1107-1118.","DOI":"10.2119\/molmed.2011.00119"},{"key":"key-10.14336\/AD.2023.0217-136","doi-asserted-by":"crossref","unstructured":"Marin R, Fabelo N, Mart\u00edn V, Garcia-Esparcia P, Ferrer I, Quinto-Alemany D, et al. (2017). Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer\u2019s and Parkinson\u2019s diseases. Neurobiol Aging, 49:52-59.","DOI":"10.1016\/j.neurobiolaging.2016.08.027"},{"key":"key-10.14336\/AD.2023.0217-137","doi-asserted-by":"crossref","unstructured":"Pera M, Larrea D, Guardia-Laguarta C, Montesinos J, Velasco KR, Agrawal RR, et al. (2017). Increased localization of APP-C99 in mitochondria-associated ER membranes causes mitochondrial dysfunction in Alzheimer disease. EMBO J, 36:3356-3371.","DOI":"10.15252\/embj.201796797"},{"key":"key-10.14336\/AD.2023.0217-138","doi-asserted-by":"crossref","unstructured":"Head BP, Patel HH, Insel PA (2014). Interaction of membrane\/lipid rafts with the cytoskeleton: impact on signaling and function: membrane\/lipid rafts, mediators of cytoskeletal arrangement and cell signaling. Biochim Biophys Acta, 1838:532-545.","DOI":"10.1016\/j.bbamem.2013.07.018"},{"key":"key-10.14336\/AD.2023.0217-139","doi-asserted-by":"crossref","unstructured":"Fabelo N, Mart\u00edn V, Mar\u00edn R, Moreno D, Ferrer I, D\u00edaz M (2014). Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer\u2019s disease and facilitates APP\/BACE1 interactions. Neurobiol Aging, 35:1801-1812.","DOI":"10.1016\/j.neurobiolaging.2014.02.005"},{"key":"key-10.14336\/AD.2023.0217-140","doi-asserted-by":"crossref","unstructured":"Fabelo N, Mart\u00edn V, Mar\u00edn R, Santpere G, Aso E, Ferrer I, et al. (2012). Evidence for premature lipid raft aging in APP\/PS1 double-transgenic mice, a model of familial Alzheimer disease. J Neuropathol Exp Neurol, 71:868-881.","DOI":"10.1097\/NEN.0b013e31826be03c"},{"key":"key-10.14336\/AD.2023.0217-141","doi-asserted-by":"crossref","unstructured":"D\u00edaz M, Fabelo N, Mart\u00edn V, Ferrer I, G\u00f3mez T, Mar\u00edn R (2015). Biophysical alterations in lipid rafts from human cerebral cortex associate with increased BACE1\/A\u03b2PP interaction in early stages of Alzheimer\u2019s disease. J Alzheimers Dis, 43:1185-1198.","DOI":"10.3233\/JAD-141146"},{"key":"key-10.14336\/AD.2023.0217-142","doi-asserted-by":"crossref","unstructured":"Fabiani C, Antollini SS (2019). Alzheimer\u2019s Disease as a Membrane Disorder: Spatial Cross-Talk Among Beta-Amyloid Peptides, Nicotinic Acetylcholine Receptors and Lipid Rafts. Front Cell Neurosci. 13:309.","DOI":"10.3389\/fncel.2019.00309"},{"key":"key-10.14336\/AD.2023.0217-143","doi-asserted-by":"crossref","unstructured":"Vetrivel KS, Thinakaran G (2010). Membrane rafts in Alzheimer\u2019s disease beta-amyloid production. Biochim Biophys Acta, 1801:860-867.","DOI":"10.1016\/j.bbalip.2010.03.007"},{"key":"key-10.14336\/AD.2023.0217-144","doi-asserted-by":"crossref","unstructured":"Demetrius LA, Eckert A, Grimm A (2021). Sex differences in Alzheimer\u2019s disease: metabolic reprogramming and therapeutic intervention. Trends Endocrinol Metab, 32:963-979.","DOI":"10.1016\/j.tem.2021.09.004"},{"key":"key-10.14336\/AD.2023.0217-145","doi-asserted-by":"crossref","unstructured":"Jov\u00e9 M, Mat\u00e9 I, Naud\u00ed A, Mota-Martorell N, Portero-Ot\u00edn M, De La Fuente M, et al. (2016). Human Aging Is a Metabolome-related Matter of Gender. Journals Gerontol - Ser A Biol Sci Med Sci. 71(5):578-85.","DOI":"10.1093\/gerona\/glv074"}],"container-title":["Aging and disease"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T14:19:00Z","timestamp":1695997140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aginganddisease.org\/EN\/10.14336\/AD.2023.0217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":145,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.14336\/ad.2023.0217","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.11.04.515175","asserted-by":"object"}]},"ISSN":["2152-5250"],"issn-type":[{"value":"2152-5250","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}